HANG ZHU: Open Payments
NPI 1669846242 · BROOKLYN, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$548 in 28 payments from 7 companies in 2025. Trend: 2023 $187 · 2024 $382 · 2025 $548
Food & beverage: $548
| Company | Payments | Amount |
|---|---|---|
| Esperion Therapeutics, Inc. | 15 | $318 |
| Madrigal Pharmaceuticals | 5 | $96 |
| Amgen Inc. | 3 | $56 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $34 |
| ABBVIE INC. | 1 | $16 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
| Novo Nordisk Inc | 1 | $14 |
Products named: NEXLETOL, REZDIFFRA, REPATHA, XIFAXAN, OTEZLA, LINZESS, ZENPEP.
Industry payments across NY — which companies pay providers there.
